AGREEMENTSchedule 13g Amendment • February 15th, 2022 • Armistice Capital, LLC • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 15th, 2022 Company IndustryThe undersigned agree that this Amendment No. 4 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of ReShape Lifesciences Inc. shall be filed on behalf of the undersigned.